Halda Therapeutics Secures $126M to Advance Novel RIPTAC Cancer Therapies
Key Highlights Halda Therapeutics raises $126M in Series B extension, total $202M funding to date. Proceeds will advance…
Browsing Tag
Deep Track Capital
2 posts
Avenzo Therapeutics Closes $150M Series A-1 Financing
Key Highlights Oversubscribed $150 million Series A-1 financing led by New Enterprise Associates, Deep Track Capital, Sofinnova Investments, and…